Valve Science for Professionals

MHIF Announces Headrick Family Chair for Valve Science Research

MHIF Announces the Roger L. and Lynn C. Headrick Family Chair for Valve Science Research

Does my patient qualify for research?

Landmark Achievements
  • First transcatheter mitral valve replacement in the U.S. Read more.
  • First-in-human therapy of severe mitral annular calcification. Read more.
  • First-in-human therapy of tricuspid regurgitation with the TriClip. Read more.
  • First-in-human therapy with the MyoCor device for treatment of mitral regurgitation. Read more.
  • First-in-human therapy of hypertrophic cardiomyopathy with MitraClip. Read more.

Latest News

MHIF Well Represented at CRT2019

Several researchers from Minneapolis Heart Institute Foundation represented at CRT2019 in Washington D.C. the first weekend in March. Amongst the team, there was a total of 43...

 

Valve Science Center Research Published in JAMA Cardiology

MHIF Valve Science Center Researchers, Drs. Miho Fukui and Joao Cavalcante authored a recent paper published in JAMA Cardiology regarding TAVR outcomes in aortic stenosis patients. Read...

Valve Science Center Featured in Delta SkyMiles Ad

Leading into Valve Disease Awareness Day (February 22), Minneapolis Heart Institute Foundation's Valve Science Center was featured in the Delta SkyMiles ad. Dr. Paul Sorajja, Roger L....

Valve Science Center Contact Form

13 + 1 =

Read about the team of physicians, scholars and staff at the Valve Science Center.